CD274 and head and neck squamous cell carcinoma: Therefore, the aim of this study was to perform additional research on the role of PD-L1 in SCCHN, focusing only on OSCC, using two clones from FDA approved kits, namely the 22C3 clone (Agilent-DAKO) and the SP142 clone (Roche), and scoring both TCs and ICs.